Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:37:10 EDT Tue 09 Jun 2026
Enter Symbol
or Name
USA
CA



Q:TRIB - TRINITY BIOTECH PLC SPON ADR EACH REP 20 ORD (POST SPLIT) - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TRIB - Q0.10.6105·2.000.10.68+0.01251.9114.8647310.6562  0.72  0.653.44  0.5071Jun 08May 0115 min RT 2¢

Recent Trades - Last 10 of 731
Time ETExPriceChangeVolume
19:24:43Q0.670.00251
19:01:43Q0.670.0025500
16:10:04Q0.680.01251
16:10:04Q0.680.01251
16:10:04Q0.680.01251
16:04:21Q0.680.01251
16:04:03Q0.680.01251
16:00:16Q0.680.01251
16:00:16Q0.680.01251
16:00:00Q0.680.0125328

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-05-01 09:27U:TRIBNews ReleaseTrinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations
2026-03-23 09:23U:TRIBNews ReleaseTrinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture(TM) Prostate Cancer Test
2026-03-18 08:30U:TRIBNews ReleaseTrinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjogren's Syndrome
2026-03-12 09:00U:TRIBNews ReleaseTrinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System
2026-03-11 09:00U:TRIBNews ReleaseTrinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM Program
2026-03-10 07:55U:TRIBNews ReleaseTrinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform
2026-03-10 07:45U:TRIBNews ReleaseTrinity Biotech Provides Business and Trading Update
2026-02-25 09:00U:TRIBNews ReleaseTrinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives
2026-02-20 17:00U:TRIBNews ReleaseTrinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares
2026-02-13 17:00U:TRIBNews ReleaseTrinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement
2026-02-10 13:28U:TRIBNews ReleaseTrinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold(TM) HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation
2026-02-10 08:00U:TRIBNews ReleaseTrinity Biotech Glucose Monitoring Innovation Achieves Unique Global Recognition: Diabetes Care Premier Hb9210(TM) HbA1c Analyser Becomes the Only System Awarded Prestigious IFCC Gold Classification for 2026
2025-12-23 08:50U:TRIBNews ReleaseTrinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives
2025-12-23 07:32U:TRIBNews ReleaseTrinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests
2025-12-15 09:15U:TRIBNews ReleaseTrinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances
2025-11-18 09:00U:TRIBNews ReleaseTrinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance Transformation
2025-11-14 09:00U:TRIBNews ReleaseTrinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test
2025-10-27 09:00U:TRIBNews ReleaseTrinity Biotech Welcomes Perceptive Advisor's Indication of Potential Debt-to-Equity Conversion - Strengthening Balance Sheet and Supporting Growth
2025-09-02 09:30U:TRIBNews ReleaseTrinity Biotech Regains Compliance with Nasdaq Listing Requirements
2025-08-21 09:00U:TRIBNews ReleaseTrinity Biotech Appoints Paul Tivnan as Non-Executive Director